IPCE 2024 Lahore, Pakistan

26/04/2026

13/04/2026

08/01/2026

Capacity Building Session by Pakistan Pharmacists Association is scheduled on *17th January* in PPA House 488-G Johar Town Lahore.

*Topic : Root Cause Analysis and CAPA as a Regulatory Requirement.*
1. Overview of Regulatory Flow.
2. Overview of Provincial Quality Control Board working.
3. Importance of Root Cause Analysis techniques.
5. Corrective Action Preventive Action.

Speaker: *Muhammad Nadeem*

Moderator : *Mehreen Naz*

*Timings: 4pm-6pm.*

All Registered Pharmacists can register for the session.

*Registration free.*
Limited slots available.
Get yourself Registered for the session and have command over this important topic.

*E-Certificates will be issued only to the members registered with PPA.*

Kindly Register yourself through the link

https://forms.gle/kTuKF9pkmJ14bfud9

*Umair ikram Dar.*
*GS Punjab*
*Pakistan Pharmacists Association*

08/03/2025

HAPPY WOMEN'S DAY, 2025

On this International Women's Day, the Pakistan Pharmacists Association (PPA) proudly celebrates the achievements, resilience, and contributions of women in healthcare, particularly in the field of pharmacy.

Women play a vital role in shaping the future of the pharmaceutical industry—whether as researchers, educators, pharmacists, or healthcare leaders. Their dedication and expertise continue to drive progress in ensuring safe and effective healthcare for all.

At PPA, we remain committed to promoting gender equality, empowering women in the profession, and fostering an environment where they can thrive and lead. Let us all work together to create a more inclusive and equitable future for women in pharmacy and beyond.

Happy Women’s Day!

07/03/2025

The Pakistan Pharmacists Association (PPA) extends its heartfelt congratulations to Dr. Obaidullah on assuming charge as the Chief Executive Officer (CEO) of the Drug Regulatory Authority of Pakistan (DRAP).

We also commend the Government of Pakistan and the Ministry of National Health Services, Regulations & Coordination for ensuring a purely merit-based appointment, which reflects a commitment to excellence in regulatory leadership.

Given Dr. Obaidullah’s exceptional qualifications, extensive experience, and deep expertise in regulatory sciences, we are confident that DRAP will achieve new heights as a globally recognized regulatory authority. This appointment is expected to significantly contribute to the growth of Pakistan’s pharmaceutical sector by enhancing the quality and standards of locally produced medicines.

The PPA assures its full support to the incumbent CEO in all his endeavors to strengthen and uplift the regulatory system for the benefit of public health and the pharmaceutical industry.

We wish Dr. Obaidullah the very best in his new role and look forward to a progressive era for DRAP and the pharmaceutical sector in Pakistan.